Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Celltrion, Inc., Apotex Inc.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
REGENERON PHARMACEUTICALS, INC.,
Appellant
v.
MYLAN PHARMACEUTICALS INC., CELLTRION,
INC., APOTEX INC.,
Appellees
______________________
2023-1395, 2023-1396
______________________
Appeals from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in Nos. IPR2021-
00880, IPR2021-00881, IPR2022-00257, IPR2022-00258,
IPR2022-00298, IPR2022-00301.
______________________
O R D E R
The parties, having so agreed,
I T I S O RDERED T HAT :
The above-captioned appeals are dismissed under Fed.
R. App. P. 42(b) with each side to bear their own costs.
July 9, 2024
Date
F OR THE COURT
ISSUED AS A MANDATE: July 9, 2024
Case: 23-1395 Document: 61 Page: 1 Filed: 07/09/2024

-- 1 of 1 --